Consideration of sex differences in medicine to improve health care and patient outcomes

JAMA - Journal of the American Medical Association

Volumn 316, Issue 18, 2016, Pages 1865-1866

  Legato, Marianne J ^a   Johnson, Paula A ^b   Manson, Joann E ^c,d  

^a College of Physicians and Sur ^*  (United States)

^b WELLESLEY COLLEGE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CARDIOVASCULAR DISEASE; COMPLICATION; CORONARY ARTERY DISEASE; DELAYED DIAGNOSIS; DIABETIC ANGIOPATHIES; FEMALE; HUMAN; MALE; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; SEX DIFFERENCE; SEXUAL DEVELOPMENT; SYMPTOM ASSESSMENT;

CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DELAYED DIAGNOSIS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PHARMACEUTICAL PREPARATIONS; PRECISION MEDICINE; SEX CHARACTERISTICS; SEX FACTORS; SYMPTOM ASSESSMENT;

EID: 84995784657     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.13995     Document Type: Short Survey

References (10)

1. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509(7500): 282-283.
2. Garcia M, Mulvagh SL, Merz CN, et al. Cardiovascular disease in women. Circ Res. 2016;118 (8):1273-1293.
3. Ghali JK, Piña IL, Gottlieb SS, et al; MERIT-HF Study Group.Metoprolol CR/XL in female patients with heart failure. Circulation. 2002;105(13):1585-1591.
4. Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (ambien, ambien cr, edluar, and zolpimist). http://www.fda.gov/Drugs/DrugSafety/ucm334033.htm. Posted January 10, 2013. Accessed October 10, 2016.
5. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348(7):583-592.
6. Os I, Bratland B,Dahlof B, et al. Female sex as an important determinant of lisinopril-induced cough. Lancet. 1992;339(8789):372.
7. Niewada M, Kobayashi A, Sandercock PAG, et al. Influence of gender on baseline features and clinical outcomes among 17 370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology. 2005;24(3):123-128.
8. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for Torsades de Pointes associated with cardiovascular drugs. JAMA. 1993;270(21):2590-2597.
9. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents. Am J Cardiol. 2003;91 (6A):39D-44D.
10. Lundberg V, Stegmayr B, Asplund K, et al. Diabetes as a risk factor formyocardial infarction: population and gender perspectives. J Intern Med. 1997;241(6):485-492.